16:08 EDT Lixte Biotechnology (LIXT) files to sell 467,393 shares of common stock for holders
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LIXT:
- Lixte Biotechnology launches new study in collaboration with NKI on LB-100
- Lixte Biotechnology provides update on progress with LB-100
- Lixte announces online publication of new pre-clinical data in BioXriv
- Lixte Biotechnology adds Lurie Cancer Center as second site in LB-100 trial
- Lixte Biotechnology announces closing of $1.05M registered direct offering